{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Observation+Period&page=2", "query": { "intervention": "Observation Period", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Observation+Period&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-11T15:07:05.632Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02050048", "title": "High Volume Lactated Ringer's Solution and Pancreatitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Pancreatitis" ], "interventions": [ { "name": "Administration of Lactated Ringer's (LR) Solution", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Endeavor Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2014-01", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2019-09-06", "last_synced_at": "2026-09-11T15:07:05.632Z", "location_count": 6, "location_summary": "Evanston, Illinois • Highland Park, Illinois • Skokie, Illinois + 3 more", "locations": [ { "city": "Evanston", "state": "Illinois" }, { "city": "Highland Park", "state": "Illinois" }, { "city": "Skokie", "state": "Illinois" }, { "city": "Plymouth", "state": "Minnesota" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT02050048" }, { "nct_id": "NCT00289289", "title": "Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atrial Fibrillation", "Tachycardia, Supraventricular", "Arrhythmia", "Bradycardia" ], "interventions": [ { "name": "Intervention Pacing Features", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medtronic Cardiac Rhythm and Heart Failure", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 400, "start_date": "2004-02", "completion_date": "2011-07", "has_results": true, "last_update_posted_date": "2012-08-08", "last_synced_at": "2026-09-11T15:07:05.632Z", "location_count": 34, "location_summary": "Little Rock, Arkansas • Rancho Mirage, California • San Diego, California + 31 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rancho Mirage", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Yuba City", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00289289" }, { "nct_id": "NCT01332968", "title": "A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-Hodgkin's Lymphoma" ], "interventions": [ { "name": "Obinutuzumab", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Bendamustine", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1401, "start_date": "2011-07-06", "completion_date": "2021-07-30", "has_results": true, "last_update_posted_date": "2022-08-11", "last_synced_at": "2026-09-11T15:07:05.632Z", "location_count": 12, "location_summary": "Springdale, Arkansas • Irvine, California • Post Falls, Idaho + 9 more", "locations": [ { "city": "Springdale", "state": "Arkansas" }, { "city": "Irvine", "state": "California" }, { "city": "Post Falls", "state": "Idaho" }, { "city": "Galesburg", "state": "Illinois" }, { "city": "Sioux City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT01332968" }, { "nct_id": "NCT05789524", "title": "The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hemophilia a", "Hemophilia B" ], "interventions": [ { "name": "SerpinPC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ApcinteX Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "12 Years to 65 Years · Male only" }, "enrollment_count": 60, "start_date": "2023-07-06", "completion_date": "2025-02-28", "has_results": false, "last_update_posted_date": "2025-03-11", "last_synced_at": "2026-09-11T15:07:05.632Z", "location_count": 10, "location_summary": "Aurora, Colorado • Tampa, Florida • Indianapolis, Indiana + 7 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05789524" }, { "nct_id": "NCT07279233", "title": "To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy", "Volunteer" ], "interventions": [ { "name": "Mirdametinib", "type": "DRUG" }, { "name": "Mirdametinib and Carbamazepine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 36, "start_date": "2025-12-15", "completion_date": "2026-02-27", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-09-11T15:07:05.632Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07279233" }, { "nct_id": "NCT07701928", "title": "Daridorexant for People With Insomnia and Alcohol Use Disorder Study", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcohol Use Disorder", "Insomnia" ], "interventions": [ { "name": "Daridorexant", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Brief Counseling", "type": "BEHAVIORAL" }, { "name": "MEMS and Medication Accounting", "type": "DEVICE" }, { "name": "Contingency Management for Medication Adherence", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "DEVICE" ], "sponsor": "Sterling McPherson", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 205, "start_date": "2026-09-01", "completion_date": "2031-12", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-09-11T15:07:05.632Z", "location_count": 1, "location_summary": "Spokane, Washington", "locations": [ { "city": "Spokane", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT07701928" }, { "nct_id": "NCT04906499", "title": "Preventing Posttraumatic Osteoarthritis With Physical Activity Promotion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anterior Cruciate Ligament Injuries", "Exercise", "Cartilage, Articular", "Knee Injuries", "Osteoarthritis", "Osteoarthritis, Knee", "Arthritis", "Joint Diseases" ], "interventions": [ { "name": "Physical Activity Promotion", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 7, "start_date": "2021-08-01", "completion_date": "2022-09-09", "has_results": true, "last_update_posted_date": "2024-01-29", "last_synced_at": "2026-09-11T15:07:05.632Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04906499" }, { "nct_id": "NCT05417932", "title": "A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hepatitis B Virus Related Hepatocellular Carcinoma", "Hepatocellular Carcinoma Recurrent" ], "interventions": [ { "name": "SCG101", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "SCG Cell Therapy Pte. Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 46, "start_date": "2022-10-26", "completion_date": "2025-10", "has_results": false, "last_update_posted_date": "2025-02-18", "last_synced_at": "2026-09-11T15:07:05.632Z", "location_count": 2, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05417932" }, { "nct_id": "NCT04255199", "title": "Watchful Waiting as a Strategy for Reducing Low-value Spinal Imaging", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Low Back Pain" ], "interventions": [ { "name": "Control", "type": "BEHAVIORAL" }, { "name": "Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, Davis", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 67, "start_date": "2020-10-21", "completion_date": "2024-11-30", "has_results": false, "last_update_posted_date": "2024-12-10", "last_synced_at": "2026-09-11T15:07:05.632Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04255199" }, { "nct_id": "NCT05151744", "title": "A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "Vamikibart", "type": "DRUG" }, { "name": "Ranibizumab", "type": "DRUG" }, { "name": "Sham Procedure", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 187, "start_date": "2021-12-17", "completion_date": "2024-10-01", "has_results": true, "last_update_posted_date": "2025-10-16", "last_synced_at": "2026-09-11T15:07:05.632Z", "location_count": 10, "location_summary": "Arcadia, California • Torrance, California • Walnut Creek, California + 7 more", "locations": [ { "city": "Arcadia", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05151744" } ] }